← Leaderboards
Shanna Alexandria Arnold
Veterans Health Administration
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2015–20$1$1$1$0$0
'15
'16
'17
'18
'19
'20
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Veterans Health Administration
Same institution · by research overlap
- Anant Madabhushi$18,556,814
- Machelle T. Pardue$7,190,905
- Philip Owens$0
- Pamela J. Vandevord$522,270
Others in their field
Top investigators on “Extracellular”
- Marinella Temprosa · George Washington University$48,628,632
- Prescott G Woodruff · University Of California San Francisco$30,601,186
- Ed Lein · Allen Institute$26,451,910
- Naftali Kaminski · Yale University$23,053,857
- Richard L Huganir · Johns Hopkins University$21,712,765
- Kristiina Vuori · Burnham Institute For Medical Research$21,402,128
Research focus
ExtracellularDissociationDisease ProgressionExcisionBladderBaseBiological MarkersActivated-Leukocyte Cell Adhesion MoleculeAnimalsCancer EtiologyCancer PatientCell AdhesionBloodCell MotilityCell SurvivalCessation Of LifeChemotherapyCleaved CellCancer Cell LineClinical CareCohortCompanion DiagnosticsDiagnosisExtracellular Domain
Grant awards (6)
ALCAM as a Biomarker of Treatment Response and Progression in Urogenital Cancers$0
IK2 · FY2020 · VA · contact PI
ALCAM as a Biomarker of Treatment Response and Progression in Urogenital Cancers$0
IK2 · FY2019 · VA · contact PI
ALCAM as a Biomarker of Treatment Response and Progression in Urogenital Cancers$0
IK2 · FY2018 · VA · contact PI
ALCAM as a Biomarker of Treatment Response and Progression in Urogenital Cancers$0
IK2 · FY2017 · VA · contact PI
ALCAM as a Biomarker of Treatment Response and Progression in Urogenital Cancers$0
IK2 · FY2016 · VA · contact PI
ALCAM as a Biomarker of Treatment Response and Progression in Urogenital Cancers$0
IK2 · FY2015 · VA · contact PI